
Medtronic plc company profile
$102.86+1.85%Close 13 Nov 2026 · Market value $132.0B · Next results 24 Nov 2026
About Medtronic plc
Medtronic plc is a healthcare technology company headquartered in Galway, Ireland, founded in 1949. It develops, manufactures, distributes, and sells device-based medical therapies and services through three reportable segments: the Cardiovascular Portfolio, the Neuroscience Portfolio, and the Medical Surgical Portfolio. Cardiovascular products include cardiac rhythm devices, cardiac ablation systems, structural heart and aortic products, and coronary and peripheral vascular products. Neuroscience products include spine and cranial technologies, neurovascular and ENT products, and neuromodulation systems. Medical Surgical products include surgical and endoscopy devices and patient monitoring and airway management products. The company sells to hospitals, physicians, clinicians, and patients, through direct sales representatives and third parties, in more than 150 countries.
A summary of the business section of the company's latest annual report, filed 18 Jun 2026.
Company facts
| Ticker | MDT · NYSE |
|---|
| Sector | Medical devices |
|---|
| Industry | Health Care Equipment |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 24 April |
|---|
| Reporting currency | USD |
|---|
| CIK | 1613103 |
|---|
| Latest annual report | 10-K, filed 18 Jun 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Geoffrey S. Martha | Chairman and CEO · Director | 2.5M | Sale under a 10b5-1 plan, 15 Oct 2026 |
|---|
| Brett Wall | EVP & Pres Neuroscience | 556K | Option exercise, 26 May 2026 |
|---|
| Michael Marinaro | President | 461K | Grant or award, 2 Nov 2026 |
|---|
| Kendall J. Powell | Director | 51.6K | Shares withheld for tax, 28 Apr 2026 |
|---|
| Randall J. Hogan, III | Director | 49.0K | Shares withheld for tax, 28 Apr 2026 |
|---|
| Craig Arnold | Director | 42.2K | Shares withheld for tax, 28 Apr 2026 |
|---|
| Scott C. Donnelly | Director | 24.3K | Shares withheld for tax, 28 Apr 2026 |
|---|
| Elizabeth G. Nabel, M.D. | Director | 19.6K | Shares withheld for tax, 28 Apr 2026 |
|---|
| Michelle Quinn | EVP, GC and Secretary | 13.1K | Grant or award, 3 Aug 2026 |
|---|
| Kevin E. Lofton | Director | 10.2K | Code J, 15 Oct 2026 |
|---|
| Lidia L. Fonseca | Director | 7.7K | Shares withheld for tax, 28 Apr 2026 |
|---|
| William R. Jellison | Director | 6.5K | Grant or award, 27 Apr 2026 |
|---|
| Gregory P. Lewis | Director | 5.8K | Shares withheld for tax, 28 Apr 2026 |
|---|
| Joon S. Lee, M.D. | Director | 1.8K | Grant or award, 27 Apr 2026 |
|---|
| John P. Groetelaars | Director | 1.5K | Grant or award, 27 Apr 2026 |
|---|
| KIIL HARRY SKIP | EVP & President Cardiovascular | — | Open-market sale, 16 Sep 2026 |
|---|
| Blomquist Denise L. | Chief Accounting Officer | — | Gift, 15 Sep 2026 |
|---|
| Thompson Kweli | EVP & President, Neuroscience | — | Grant or award, 3 Aug 2026 |
|---|
| Pieton Thierry | EVP & Chief Financial Officer | — | Grant or award, 3 Aug 2026 |
|---|
| Walter Matthew R. | SVP, Chief HR Officer | — | Grant or award, 3 Aug 2026 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
MDT in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.